Daily non-political popular news in brief.

Asthmatx completes enrollment in pivotal study of bronchial thermoplasty

Final results of the first randomized and controlled clinical study of bronchial thermoplasty, the Asthma Intervention Research Trial, were reported today at the annual scientific assembly of the American Thoracic Society. This follows the March publication of the AIR Trial results in the New England Journal of Medicine. These results include patients treated with the outpatient procedure demonstrated a 50 percent decrease in asthma attacks and a 45 percent reduction in rescue medication use.

Read more »

Keywords: asthmatx, completes, enrollment, pivotal, study, bronchial, thermoplasty, complete

« Previous | Next »

Similar news on "Asthmatx completes enrollment in pivotal study of bronchial thermoplasty":

1. Groundbreaking Canadian asthma study
   03-28-2007 · EurekAlert!
   Study shows that patients treated with bronchial thermoplasty, the first non-drug treatment for asthma, demonstrated an overall improvement in asthma control.
   Similar news · Read more »
   
2. Drivers on cell phones clog traffic
   01-01-2008 · EurekAlert!
   Motorists who talk on cell phones drive slower on the freeway, pass sluggish vehicles less often and take longer to complete their trips, according to a University of Utah study that suggests drivers on cell phones congest traffic. "At the end of the day, the average person's commute is longer because of that person who is on the cell phone right in front of them," says psychologist Dave Strayer, leader of the research team.
   Similar news · Read more »
   
3. Bronchial thermoplasty may allow severe asthma patients to wean off oral corticosteroids
   05-23-2007 · EurekAlert!
   Positive results from the Research in Severe Asthma (RISA) Trial of Bronchial Thermoplasty were reported today at the annual scientific assembly of the American Thoracic Society (ATS). Clinically and statistically significant improvements in pulmonary function, asthma control, and quality of life, as well as a reduction in use of rescue medications, were observed following the bronchial thermoplasty procedure in patients with severe asthma. Bronchial Thermoplasty is first non-drug treatment for asthma.
   Similar news · Read more »
   
4. People with genetic predictors of colorectal cancer are not getting screened
   02-22-2007 · EurekAlert!
   Even when diagnosed with a condition that is a strong genetic predictor of colorectal cancer, many patients do not seek out genetic counseling or cancer screening. According to a recent study in the American Journal of Gastroenterology, counseling and screening rates could be improved if physicians provided stronger encouragement and more complete information about the benefits of screening to their patients.
   Similar news · Read more »
   
5. 2 genes found to play crucial role in cell survival
   02-04-2008 · EurekAlert!
   New research suggests that two recently discovered genes are critically important for controlling cell survival during embryonic development. The genes, called E2F7 and E2F8, are members of a family of genes that play a fundamental role in development. Members of this family are also involved in cancers of the breast, bladder, stomach and colon. This animal study showed that complete loss of the two genes causes massive cell death and is lethal in developing embryos.
   Similar news · Read more »
   
6. 1-year results of bronchial thermoplasty in refractory asthma
   02-11-2008 · EurekAlert!
   Data from the Research in Severe Asthma trial of bronchial thermoplasty published in the American Journal of Respiratory and Critical Care Medicine show that patients experienced long term improvement in pulmonary function, improved quality of life and asthma control, and a reduction in rescue medication use for patients treated with bronchial thermoplasty.
   Similar news · Read more »
   
7. Cognitive lock-in: Why you can't teach an old dog new tricks
   06-04-2007 · EurekAlert!
   The ability to learn from experience is of central importance to human existence. It allows us to acquire the skills we need to complete complicated, multistep tasks in an efficient manner. It also creates habit -- a critical, if often overlooked factor in the choices consumers make. A new study from the Journal of Consumer Research demonstrates how this "cognitive lock-in" can cause us to remain loyal to a product, even if objectively better alternatives exist.
   Similar news · Read more »
   
8. A genetic variant increases the risk of developing schizophrenia in women
   02-14-2008 · EurekAlert!
   A complete scan of the human genome has revealed that a genetic variant in the Reelin gene increases the risk of developing schizophrenia in women only. Researchers from the Hebrew University of Jerusalem and the University of Oxford, who conducted the study in the Ashkenazi Jewish population, confirmed their findings by establishing a multinational collaboration that included populations and researchers from the United Kingdom, Ireland, United States, and China. Their research is published in the February issue of the open-access journal PLoS Genetics.
   Similar news · Read more »
   
9. Study demonstrated AMITIZA (lubiprostone) showed efficacy
   10-23-2006 · EurekAlert!
   Results of a secondary analysis of two pivotal studies were presented today at the 71st Annual Meeting of the American College of Gastroenterology (ACG), and showed that 60 percent of patients treated with AMITIZA (TM) (lubiprostone) experienced a spontaneous bowel movement (SBM) within 24 hours of treatment, and 80 percent experienced a SBM within 48 hours of treatment.
   Similar news · Read more »
   
10. Ovation further advances development pipeline with new phase III epilepsy study
    09-04-2007 · EurekAlert!
    Ovation Pharmaceuticals is initiating a pivotal Phase III clinical trial for clobazam, a unique 1,5 benzodiazapine with significant anticonvulsant properties, as adjunctive treatment for patients with Lennox-Gastaut syndrome, one of the most severe forms of childhood epilepsy that frequently persists into adulthood. LGS is a rare and debilitating form of epilepsy. Clobazam represents one of five CNS launches Ovation expects over the next five years.
    Similar news · Read more »